Creative Medical Technology

CELZNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$4.631 M

$0.61 -13.21%

Close of 6 Nov 2026

As of 6 Nov 2026, Creative Medical Technology (CELZ) has a market capitalization of $4.63M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$6.00K

#3608 by revenue

Earnings

-$6.00M

Loss-making

Shares outstanding

7,597,557

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#153AIM ImmunoTechAIM$6.14M
#154CurisCRIS$5.84M
#155Creative Medical TechnologyCELZ$4.63M
#156Black TitanBTTC$4.33M
#157PharmaCyte BiotechPMCB$4.03M

What if Creative Medical Technology were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,719,020

Per share 6,097,754× higher

Bitcoin $1.53T

$201,229.69

Per share 329,939× higher

Apple $5.02T

$660,618.30

Per share 1,083,158× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Creative Medical Technology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.